Widespread b29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 32, Issue 5-6, 1999, Pages 561-569

  Thompson, Alexis A ^a,c   Do, Ha Nancy ^a   Saxon, Andrew ^b   Wall, Randolph ^b,c  

^a Division of Hematology Oncology   (United States)

^b Dept of Microbiology and Immunology ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CLL; Immunoglobulin; Mutations; SSCP

Indexed keywords

B LYMPHOCYTE ANTIGEN; B29 ANTIGEN; CD5 ANTIGEN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; GENE DELETION; HUMAN; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION;

EID: 0032977898     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058414     Document Type: Article

References (31)

1. Rozman, C. and Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 1052-7.
2. O'Brien, S., del Giglio, A., and Keating, M. (1995) Advances in the biology and treatment of B-cell chronic leukemia. Blood, 85, 307-18.
3. DiGiuseppe, J.A. and Borowitz, M.J. (1998) Clinical utility of flow cytometry in the chronic lymphoid leukemias. Seminars in Oncology, 25, 6-10.
4. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., and Binet, J.L. (1991) B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood, 78, 1901-14.
5. Batata, A. and Shen, B. (1992) Immunophenotyping of sub-types of B-chronic (mature) lymphoid leukemia. A study of 242 cases. Cancer, 70, 2436-43.
6. Berntorp, E. and Zettervall, O. (1985) High expression of lymphocyte surface immunoglobulin in chronic lymphocytic leukaemia may be a bad prognostic sign. Scandinavian Journal of Haematology, 34, 213-8.
7. Baldini, L., Mozzana, R., Cortelezzi, A., Neri, A., Radaelli, F., Cesana, B., Maiolo, AT., and Polli, E.E. (1985) Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia. Blood, 65, 340-4.
8. Geisler, C.H., Larsen, J.K., Hansen, N.B., Hansen, M.M., Christensen, B.E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E., and et al. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78, 1795-802.
9. Pianezze, G., Gentilini, I., Casini, M., Fabris, P., and Coser, P. (1987) Cytoplasmic immunoglobulins in chronic lymphocytic leukemia B cells. Blood, 69, 1011-4.
10. Wood, W.J., Jr., Thompson, A.A., Korenberg, J., Chen, X.N., May, W., Wall, R., and Denny, C.T. (1993) Isolation and chromosomal mapping of the human immunoglobulin-associated B29 gene (IGB). Genomics, 16, 187-92.
11. Campbell, K.S., Hager, E.J., Friedrich, R.J., and Cambier, J.C. (1991) IgM antigen receptor complex contains phosphoprotein products of B29 and mb-1 genes. Proceedings of the National Academy of Sciences of the United States of America, 88, 3982-6.
12. Hermanson, G.G., Eisenberg, D., Kincade, P.W., and Wall, R. (1988) B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells. Proceedings of the National Academy of Sciences of the United States of America, 85, 6890-4.
13. Burkhardt, A.L., Costa, T., Misulovin, Z., Stealy, B., Bolen, J.B., and Nussenzweig, M.C. (1994) Ig alpha and Ig beta are functionally homologous to the signaling proteins of the T-cell receptor. Molecular and Cellular Biology, 14, 1095-103.
14. Costa, T.E., Franke, R.R., Sanchez, M., Misulovin, Z., and Nussenzweig, M.C. (1992) Functional reconstitution of an immunoglobulin antigen receptor in T cells. Journal of Experimental Medicine, 175, 1669-76.
15. Sanchez, M., Misulovin, Z., Burkhardt, A.L., Mahajan, S., Costa, T., Franke, R., Bolen, J.B., and Nussenzweig, M. (1993) Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. Journal of Experimental Medicine, 178, 1049-55.
16. Papavasiliou, F., Misulovin, Z., Suh, H., and Nussenzweig, M.C. (1995) The role of Ig beta in precursor B cell transition and allelic exclusion. Science, 268, 408-11.
17. Gong, S. and Nussenzweig, M.C. (1996) Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science, 272, 411-4.
18. Geisler, C.H., Philip, P., and Hansen, M.M. (1989) B-cell chronic lymphocytic leukaemia: clonal chromosome abnormalities and prognosis in 89 cases. European Journal of Haematology, 43, 397-403.
19. Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Guneo, A., Knuutila, S., and et al. (1990) Prognostic sub-groups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720-4.
20. Juliusson, G. and Gahrton, G. (1990) Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genetics and Cytogenetics, 45, 143-60.
21. Nakamura, T., Kubagawa, H., and Cooper, M.D. (1992) Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 89, 8522-6.
22. Thompson, A.A., Talley, J.A., Do, H.N., Kagan, H.L., Kunkel, L., Berenson, J., Cooper, M.D., Saxon, A., and Wall, R. (1997) Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood, 90, 1387-94.
23. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S., and Rai, K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-7.
24. Zwiebel, J.A. and Cheson, B.D. (1998) Chronic lymphocytic leukemia: staging and prognostic factors. Seminars in Oncology, 25, 42-59.
25. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-9.
26. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proceedings of the National Academy of Sciences of the United States of America, 86, 2766-70.
27. Hayashi, K. and Yandell, D.W. (1993) How sensitive is PCR-SSCP? Human Mutation, 2, 338-46.
28. Imamura, J., Miyoshi, I., and Koeffler, H.P. (1994) p53 in hematologic malignancies. Blood, 84, 2412-21.
29. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., and et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
30. Wengler, G.S., Notarangelo, L.D., Berardelli, S., Pollonni, G., Mella, P., Fasth, A., Ugazio, A.G., and Parolini, O. (1995) High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood, 86, 3648-54.
31. Puck, J.M., Pepper, A.E., Henthorn, P.S., Candotti, F., Isakov, J., Whitwam, T., Conley, M.E., Fischer, R.E., Rosenblatt, H.M., Small, T.N., and Buckley, R.H. (1997) Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood, 89, 1968-77.